| # | Drug | Count |
|---|---|---|
| 0 | EMPAGLIFLOZIN | 6 |
| 1 | GLIMEPIRIDE | 6 |
| 2 | SERTRALINE | 6 |
| 3 | SITAGLIPTIN | 6 |
| 4 | METFORMIN | 5 |
| 5 | METFORMIN ER 500 MG | 5 |
| 6 | METFORMIN ER 750 MG | 5 |
| 7 | NIVOLUMAB | 3 |
| 8 | AXITINIB | 2 |
| 9 | CISPLATIN | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CAPLACIZUMAB | 1 | 0.0006 |
| 1 | DAPRODUSTAT | 1 | 0.0005 |
| 2 | PYRIDOSTIGMINE BROMIDE | 2 | 0.0003 |
| 3 | ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE | 1 | 0.0002 |
| 4 | GLIMEPIRIDE | 6 | 0.0002 |
| 5 | CILTACABTAGENE AUTOLEUCEL | 1 | 0.0002 |
| 6 | EDOXABAN TOSYLATE | 1 | 0.0001 |
| 7 | PHYTONADIONE | 1 | 0.0001 |
| 8 | AXITINIB | 2 | 0.0001 |
| 9 | EMPAGLIFLOZIN | 6 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 1 | 0.0004 |
| 1 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 6 | 0.0002 |
| 2 | Vitamin K [EPC] | 1 | 0.0001 |
| 3 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 6 | 0.0001 |
| 4 | Sulfonylurea [EPC] | 6 | 0.0000 |
| 5 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 3 | 0.0000 |
| 6 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Angiotensin Converting Enzyme Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Platinum-based Drug [EPC] | 2 | 0.0000 |